Australia Breaking News

Paradigm Biopharmaceuticals (ASX:PAR) appointed Dr Daniel Furtner as chief medical officer, effective Sept. 16.

US President Donald Trump has waded into the AI safety debate raging between Silicon Valley and Washington. In a rapid-fire series of social media posts, Trump belittled a push led by Anthropic and OpenAI bosses to slow work on cutting-edge systems and dismissed the existential fears about AI as "a hoax." Michael Wade, Professor of Strategy and Digital at the IMD business school in Switzerland spoke to Bloomberg's Abeer Abu Omar on the need for AI guardrails.

Leeuwin Metals (ASX:LM1) appointed mining engineer Rubei Ma as chief development officer to advance the Marda Gold Project.

The global debate over AI safety is intensifying, as President Trump dismisses industry calls for a slowdown as a "conspiracy theory," and China brands fresh warnings about the tech "fearmongering." At the same time, Australia's cyber intelligence chief, Abigail Bradshaw, says the country needs an AI early warning system to guard against risks. Scientia Professor of AI at the University of New South Wales, Toby Walsh, joins "Bloomberg: The Asia Trade" to discuss the outlook for AI regulation in Australia.

Falcon Metals (ASX:FAL) secured $30 million through an institutional share placement to expand multi-rig exploration programmes.

Australian defence firm Overwatch Technologies has lodged a prospectus to raise $8 million.

Hugging Face Researcher & Chief Ethics Scientist Margaret Mitchell believes if done well, ethics can drive innovation in artificial intelligence instead of slowing it down. She speaks with Haslinda Amin on "Insight with Haslinda Amin.

Australian Rare Earths (ASX:AR3) completed follow-up drilling that extended the Overland carbonatite discovery.

Australian first homebuyer mortgage applications dropped 20.1% in the year to August, according to credit data from Equifax.

Trek Metals (ASX:TKM) has secured an exclusive nine-month option to acquire 100% of Solution Mining.

Mayne Pharma (ASX:MYX) secured exclusive five-year Australian rights to commercialise menopause gel Blissel.

Helix Resources (ASX:HLX) entered into a binding agreement with CuFe (ASX:CUF) to acquire 30 exploration tenements.